Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04454957
Other study ID # 20-X-96
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 24, 2020
Est. completion date June 30, 2040

Study information

Verified date August 2023
Source Ohio University
Contact David Drozek, DO
Phone 678-447-2509
Email drozek@ohio.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a program evaluation that will evaluate the effectiveness of Mastering Diabetes, a therapeutic lifestyle change (TLC) program to control prediabetes and type 2 diabetes. Lifestyle change, focused on dietary change, physical activity, stress management and control of unhealthy substances has been demonstrated effective in preventing the progression of prediabetes, as well as reversal of diabetes and type 2 diabetes mellitus (T2DM).


Description:

This will be a nonrandomized controlled study. Participants will self select to be a part of this intervention. The control data will be aggregated matched data from participants in the corporate wellness program at Memorial Health System, who choose not to participate in the intervention. Study participants will have met the inclusion criteria. Potential participants will be provided with a short summary of this program as a potential activity for their participation, with a link leading to a landing page, which will explain the study in more detail, and will include a link to the consent. If the potential participant is interested, they can click the link to move to the on line consent. If they agree to the consent, they will be taken to an on line HIPAA release form, which will also need an electronic agreement to be enrolled into the study signified by typing in the participant's name and date of birth. Once this is completed, an email with an enrollment code and link to Mastering Diabetes will be sent the participant. Mastering Diabetes Program Description: The Mastering Diabetes Program is based on the Mastering Diabetes Method, which is based on almost 100 years of evidence based research demonstrating the effectiveness of a low-fat, plant-based, whole-food diet to reverse insulin resistance. Members are provided with a step-by-step online course that educates them how to transition to a low-fat, plant-based, whole-food lifestyle and reduce the overwhelm associated with ineffective pharmaceutical medication and ineffective dietary advice. The online course provides members with detailed information about the root cause of insulin resistance, the effect of a high-fat diet on increasing insulin resistance, how to achieve excellent blood glucose values in the short-term and in the long-term, what laboratory tests to get to measure progress, an overview of oral diabetes medication and insulin, how to track hour-by-hour decisions for excellent blood glucose control, how to lose weight permanently using a low-fat, plant-based, whole-food diet, how to buy food, where to buy food, how to prepare food easily, the benefits of intermittent fasting for improved insulin sensitivity, how to perform an intermittent fast for excellent results, how to adopt an exercise regimen, how to control your blood glucose before, during, and after exercise, how to change your breakfast, lunch, dinner, and also provides members with a collection of delicious and simple recipes. The program also provides members with direct access to expert coaches via an online community containing thousands of others living with all forms of diabetes, including type 1 diabetes, type 1.5 diabetes, prediabetes, type 2 diabetes, and gestational diabetes. In addition, members get access to live biweekly Q&A videoconferences in which they can interact with coaches and personalize their experience. The cost of full coaching program is $399 for the first 3 months, then $99 per month thereafter. Participants, having enrolled in the wellness program, will already, as a part of that study, have agreed to have data collected at baseline and yearly thereafter, including BMI, blood pressure, resting pulse, lipid panel, hemoglobin A1c, health risk assessment survey, absenteeism and health claims data at baseline and yearly thereafter. If not collected within 60 days, a new set of data will be collected to serve as baseline for this study. This is not specific for this study, but is the case for any new program activity that a participant in the corporate wellness study begins. Specifically for this study the health risk assessment data collection (including lab analysis) will also be repeated at 12 weeks. The lab work is accomplished at any MHS lab facility, according to current medical system standards. Participant health claims data will also be evaluated, beginning with the prior year's data, if available from MHS Human Resources, being utilized as a baseline, and followed for the subsequent years of the study.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date June 30, 2040
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age 18-75 years at enrollment - Has a diagnosis of diabetes or prediabetes or a HbA1c of 5.7 or higher. - Are able to participate in physical activity. - Are willing to use a smartphone or computer to access the online education modules and online community, and have reliable daily Internet access with a device with a webcam - Have an email account and an Internet connection at home - Are able to purchase and transport fresh produce from a local grocery store to their house on a weekly basis - Are able to prepare food in their house or get help preparing food in their house following recipes and meal examples provided in the online course - Are open-minded about eating a plant-based diet, performing periodic intermittent fasting (16-24 hours, once a week), - Are willing to increase movement of their body 5-6 days per week - Are willing to participate in an online community for support and coaching - Are willing to participate in biweekly videoconferencing for support and coaching - Are willing to be courteous and respectful to others in the online community Exclusion Criteria: - Has been told by a medical provider to not participate in physical activity. - Has a medical condition that prevents walking at least a mile a day. - Deemed unsuitable to exercise by Dr. Drozek or other members of the wellness team. - Has a diagnosis of dementia. - Is pregnant or planning to become pregnant during the program - Does not speak or understand English - Advanced renal disease (stage 4 or 5) with or without hemodialysis - Congestive heart failure - Has inflammatory bowel disease (Crohns disease, ulcerative colitis) - Is fed by a feeding tube - Is taking Coumadin or warfarin - Inability to use email, a smartphone, or the Internet

Study Design


Intervention

Behavioral:
Mastering Diabetes
Virtual (on-line) lifestyle change program, focused on a plant-based, whole food diet and physical activity.

Locations

Country Name City State
United States Ohio University Athens Ohio

Sponsors (2)

Lead Sponsor Collaborator
Ohio University Memorial Health System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary HbA1c glycosylated hemoglobin measured from venous blood up to 20 years
Primary BMI Body mass index calculated from height and weight up to 20 years
Primary Healthcare expenditures Monetary amount spent for healthcare up to 20 years
Secondary Total cholesterol Measured from a lipid panel done on venous blood baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Secondary Low density lipoprotein cholesterol Calculated from a lipid panel done on venous blood baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Secondary High density lipoprotein cholesterol Measured from a lipid panel done on venous blood baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Secondary Triglyceride Measured from a lipid panel done on venous blood baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Secondary Exercise level Amount of time spent per week in moderate to vigorous physical activity baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Secondary Dietary Recall Daily or weekly average of foods consumed during the last 7 days baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Secondary Patient Health Questionnaire mood screening questions; two for anxiety baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Secondary Patient Health Questionnaire mood screening questions; two for depression. baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2